Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of tadalafil on cerebral large arteries in stroke patients
2016-000896-26Phase 2Completed
- Sponsor
- Herlev & Gentofte Hospital
- Start
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of tadalafil in Cerebral Small Vessel Disease (CSVD) and stroke, sponsored by Herlev & Gentofte Hospital. Primary endpoints: Change in mean blood flow velocity in the middle cerebral artery and Change in cortical brain oxygenation. Started Mar 2016; status: completed.
02
Drugs
tadalafil
03
Conditions
Cerebral Small Vessel Disease (CSVD)stroke
Beyond the preview
Go deeper on 2016-000896-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-000896-26.